This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication


Personalized brain modeling technique may lead to breakthroughs in clinical epilepsy trial

Personalized brain modeling technique may lead to breakthroughs in clinical epilepsy trial
Left: clinical estimation of the epileptogenic areas in a patient's brain (in blue) based on invasive electrode insertion (yellow). Right: The Virtual Brain has identified additional areas for removal (red) in the same patient that were undetected in the previous estimation. Credit: V. Jirsa

Researchers of the Human Brain Project (HBP) have published a new study in Science Translational Medicine presenting advanced brain modeling methods for epilepsy clinical care. The article, which is featured on this week's cover of the journal, describes the methodology used in the EPINOV clinical trial (Improving Epilepsy surgery management and progNOsis using Virtual brain technology).

The personalized brain modeling approach has been developed over several years in the HBP, and is supported by the digital research infrastructure EBRAINS.

To create personalized brain models, the researchers use a called The Virtual Brain (TVB), which HBP scientist Viktor Jirsa has developed together with collaborators. For each patient, the computational models are created from individually measured anatomy, structural connectivity and brain dynamics data.

For , the approach is currently being tested in a large-scale clinical trial to provide a computational, predictive tool in surgery preparation

Even though for many patients, epileptic seizures can be controlled by drugs, almost one-third of do not respond to medication. For this group, surgical removal of the epileptogenic zone, the brain area from which the seizure originates and propagates, presents the only treatment option. Currently, the procedure has a 60% success rate.

The TVB technology enables clinicians to simulate the spread of abnormal activity during in a patient's brain, helping them to identify the target areas better. The simulations are personalized for each patient, effectively providing a virtual epileptic patient (VEP) tailored to each individual real one. The approach has been tested in several retrospective studies, the latest one published this year in Epilepsia. The clinical trial is expected to run until 2025.

Ongoing work in the HBP uses the EBRAINS research infrastructure to further improve the method's predictive power with new high-resolution data from the HBP's multilevel human brain atlas.

"Computational neuromedicine needs to integrate high-resolution data and patient specificity," explains Jirsa. "Our approach heavily relies on the research technologies in EBRAINS and could only have been possible in a large-scale, collaborative project such as the HBP."

More information: Huifang E. Wang et al, Delineating epileptogenic networks using brain imaging data and personalized modeling in drug-resistant epilepsy, Science Translational Medicine (2023). DOI: 10.1126/scitranslmed.abp8982

Provided by Human Brain Project
Citation: Personalized brain modeling technique may lead to breakthroughs in clinical epilepsy trial (2023, January 26) retrieved 30 March 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New EBRAINS-enabled tool to help guide surgery in drug-resistant epilepsy patients


Feedback to editors